PARP inhibitors for BRCA wild type ovarian cancer; gene alterations, homologous recombination deficiency and combination therapy
- Koji Matsumoto
- , Meiko Nishimura
- , Takuma Onoe
- , Hideki Sakai
- , Yusaku Urakawa
- , Takashi Onda
- , Nobuo Yaegashi
研究成果: ジャーナルへの寄稿 › 総説 › 査読
27
!!Link opens in a new tab
被引用数
(Scopus)